TB31F
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for TB31F, covering 2023-03-27 to 2026-01-22. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Pharmacokinetics, and Plasmodium Falciparum Transmission-reducing Activity of Monoclonal Antibody TB31F in Mali [Phase 1, Phase 2]